title: Targeted therapy for thyroid cancer: striking the survival signaling.
authors.forename: Mario
authors.initials: M
authors.lastname: Vitale
mesh_terms: D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D017209:Apoptosis / Q000187:drug effects* / Q000235:genetics; D018265:Carcinoma, Papillary, Follicular / Q000188:drug therapy* / Q000235:genetics; D002470:Cell Survival / Q000187:drug effects / Q000235:genetics; D019008:Drug Resistance, Neoplasm / Q000187:drug effects / Q000235:genetics; D006801:Humans; D020930:MAP Kinase Kinase Kinases / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism / Q000502:physiology; D020935:MAP Kinase Signaling System / Q000235:genetics / Q000502:physiology; D058990:Molecular Targeted Therapy / Q000379:methods* / Q000639:trends; D015398:Signal Transduction / Q000187:drug effects / Q000235:genetics; D013964:Thyroid Neoplasms / Q000188:drug therapy* / Q000235:genetics; D048490:raf Kinases / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism / Q000502:physiology
chemical_list: D000970:Antineoplastic Agents; D048490:raf Kinases; D020930:MAP Kinase Kinase Kinases